Derrina Wu
Internal Medicine · San Francisco, CANPI 1659387892
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (59.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Gilead at 46.5% of the total. Reporting peaked in 2019 at $3,613 and has fallen 91.9% since, to $294 in 2022. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 187 payments — averaging $31.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$3K
- Pfizer$426
- Johnson & Johnson$414
- AbbVie$377
- Amarin Pharma, Inc.$263
- AstraZeneca$246
- plus $1K from 14 others
What the payments were for
- Consulting fees$2,10035%
- Travel & lodging$3005%
- Food & beverage$3,55659%
- Education$240%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 27 | $2,778 |
| Pfizer | 24 | $426 |
| Johnson & Johnson | 21 | $414 |
| AbbVie(2 entities) | 21 | $377 |
| Amarin Pharma, Inc. | 13 | $263 |
| AstraZeneca | 12 | $246 |
| Novo Nordisk | 12 | $215 |
| Biohaven Pharmaceuticals, Inc. | 8 | $204 |
| Lilly USA, LLC | 12 | $199 |
| Merck | 10 | $177 |
| Amgen | 7 | $156 |
| Bardy Diagnostics, Inc. | 3 | $152 |
| Kowa Pharmaceuticals America, Inc. | 5 | $133 |
| Radius Health, Inc. | 3 | $77 |
| E.r. Squibb & Sons, L.L.C. | 3 | $62 |
| Boehringer Ingelheim | 2 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| GSK | 1 | $23 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vemlidy$2,400
- Carnation Ambulatory Monitor$100
How this compares
$5,980 in reported general payments places this provider in the 90th percentile of 13,581 internal medicine providers in California.
Other internal medicine in San Francisco
- Fred CohenSan Francisco$929K
- John TeerlinkSan Francisco$819K
- Mark SmithSan Francisco$535K
- Lisa CapaldiniSan Francisco$434K
- Maria Dall'eraSan Francisco$417K
- Kenneth ColleySan Francisco$397K
- Louis CubbaSan Francisco$351K
- Daniel ButlerSan Francisco$347K
- Laurence CorashSan Francisco$336K
- Felicia StermanSan Francisco$298K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.